Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: Giuseppe Scalamogna who wrote (493)	1/7/1998 10:54:00 AM
From: FNS	Respond to of 965

Hi Giuseppe and Bruce (Pancho still in Brasil?), et al: G, I agree with your assessment and would throw in another factor for the delay; i.e., the climate is not too good at this time! -- Asian monetary crisis and corporate jitters here...and also, IMNX is still in the ballgame ahead of CNTO on the arthritis approval (IMO). So, much to consider. On the other hand, while it may be great to get a partner quickly, like this month, I hope the deal is a GOOD one for CNTO! Further, I'd sure like to know why the previous deal didn't GO! Anyone privy to that kind of info? Ciao! FNS

To: Giuseppe Scalamogna who wrote (493)	1/7/1998 5:52:00 PM
From: PawPr	Read Replies (2) \| Respond to of 965

I'M NOT AWARE THAT ANY COMPANY "PULLED OUT", JUST THAT THEY COULDN'T NEGOTIATE A FINAL DEAL. MAYBE THEY HAD SEVERAL COMPETING OFFERS. IT'S A MOOT POINT UNTIL THE DRUG ( AVAKINE ) IS APPROVED ANYWAY.